URGN
UroGen Pharma Ltd.
$25.87
+$1.03(+4.15%)
53
Overall
40
Value
66
Tech
--
Quality
Market Cap
$1.10B
Volume
773.74K
52W Range
$3.42 - $26.28
Target Price
$34.88
Key Metrics Overview
| Market Cap | $1.10B | P/E Ratio | N/A |
| 52W High | $26.28 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 15.8% | 52W Position | 98.2% |
| Overall Score | 53 | Value Score | 40 |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-3.22 | EPS Next Est | $-1.14 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $25.87 | +4.1% | 773.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |